Par plans to launch a generic version of GlaxoSmithKline's (NYSE: GSK) Imitrex in the fourth quarter and has a few more possibilities for 2009 and beyond, ...
... after a number of online pharmacies started catering to the Bahamian market, offering a growing list of drugs like Viagra, Levitra, Vioxx and Imitrex. ...
... after a number of online pharmacies started catering to the Bahamian market, offering a growing list of drugs like Viagra, Levitra, Vioxx and Imitrex. ...
Four more drugs will lose patent protection by the end of 2008, including the migraine pill Imitrex and the epilepsy treatment Lamictal, medicines that ...
The drug is the generic version of GlaxoSmithKline's Imitrex, which had annual sales of about $950 million for the indicated strengths.
Sumatriptan Succinate tablets are the generic version of GlaxoSmithKline's Imitrex Tablets. The terms of the settlement, provide that Ranbaxy may distribute ...
End of 2008: Migraine pill Imitrex will lose patent protection. Treximet, if approved, would replace Imitrex. GlaxoSmithKline is forfeiting $1.4 million in ...
... to possible patent litigation with GlaxoSmithKline relating to Sumatriptan Succinate Tablets, the generic version of GlaxoSmithKline's Imitrex Tablets. ...
Four more drugs will lose patent protection by the end of 2008, including the migraine pill Imitrex and the epilepsy treatment Lamictal, medicines that ...
Some of its best-selling drugs, including migraine pill Imitrex and anti-depressant Paxil, are on track to lose patent protection. ...